GSK-180

N/A

Report date: 2025/03/19 16:00:09
NME

Base Information

Drug NameGSK-180
Drug Alias NameGSK-180
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionKynurenine 3-monooxygenase inhibitors
TargetsKynurenine 3-monooxygenase
Therapy Area/IndicationsMultiple Organ FailurePancreatitis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesGlaxosmithkline Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGlaxosmithkline Plc
Active IndicationsN/A
Inactive IndicationsMultiple Organ FailurePancreatitis

Other Information

ATC CodeN/A
Related LinksN/A